cbdMD, Inc.
YCBD
$0.86
-$0.05-5.50%
AMEX
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 12.23% | -11.93% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 12.23% | -11.93% | |||
| Cost of Revenue | -18.53% | 18.76% | |||
| Gross Profit | 38.59% | -27.90% | |||
| SG&A Expenses | -0.35% | -9.61% | |||
| Depreciation & Amortization | 3.54% | 0.00% | |||
| Other Operating Expenses | 171.37% | -247.73% | |||
| Total Operating Expenses | 6.71% | -12.29% | |||
| Operating Income | 72.74% | 17.12% | |||
| Income Before Tax | 109.88% | -133.24% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 109.88% | -133.24% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 109.88% | -133.24% | |||
| EBIT | 72.74% | 17.12% | |||
| EBITDA | 835.07% | 69.46% | |||
| EPS Basic | -23.01% | -16.94% | |||
| Normalized Basic EPS | 65.55% | 56.48% | |||
| EPS Diluted | -21.90% | -18.01% | |||
| Normalized Diluted EPS | 65.55% | 56.48% | |||
| Average Basic Shares Outstanding | -30.66% | 82.70% | |||
| Average Diluted Shares Outstanding | -30.66% | 82.70% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||